Gray Laura J, Tringham Jennifer R, Davies Melanie J, Webb David R, Jarvis Janet, Skinner Timothy C, Farooqi Azhar M, Khunti Kamlesh
Department of Health Sciences, University of Leicester, Leicester, UK.
Vasc Health Risk Manag. 2010 Oct 5;6:837-42. doi: 10.2147/VHRM.S12504.
Screening enables the identification of type 2 diabetes mellitus (T2DM) during its asymptomatic stage and therefore allows early intervention which may lead to fewer complications and improve outcomes. A targeted screening program was carried out in a United Kingdom (UK) multiethnic population to identify those with abnormal glucose tolerance.
A sample of individuals aged 25-75 years (40-75 white European) with at least one risk factor for T2DM were invited for screening from 17 Leicestershire (UK) general practices or through a health awareness campaign. All participants received a 75 g oral glucose tolerance test, cardiovascular risk assessment, detailed medical and family histories and anthropometric measurements.
In the 3,225 participants who were screened. 640 (20%) were found to have some form of abnormal glucose tolerance of whom 4% had T2DM, 3% impaired fasting glucose (IFG), 10% impaired glucose tolerance (IGT) and 3% both IFG and IGT. The odds of detecting IGT was approximately 60% greater (confounder-adjusted odds ratios [OR] 1.67 [1.22-2.29]) in the South Asian population.
Around one in five people who had targeted screening have IGT, IFG or T2DM, with a higher prevalence in those of South Asian origin. The prevalence of undetected T2DM is lower in South Asians compared to previously published studies and maybe due to increased awareness of this group being at high risk.
筛查能够在2型糖尿病(T2DM)的无症状阶段将其识别出来,从而实现早期干预,这可能会减少并发症并改善预后。在英国的一个多民族人群中开展了一项针对性筛查项目,以识别糖耐量异常者。
邀请年龄在25 - 75岁(40 - 75岁的白人欧洲人)且至少有一项T2DM风险因素的个体,从英国莱斯特郡的17家全科诊所或通过健康宣传活动参与筛查。所有参与者均接受75克口服葡萄糖耐量试验、心血管风险评估、详细的病史和家族史以及人体测量。
在接受筛查的3225名参与者中,640人(20%)被发现存在某种形式的糖耐量异常,其中4%患有T2DM,3%为空腹血糖受损(IFG),10%为糖耐量受损(IGT),3%同时存在IFG和IGT。在南亚人群中检测到IGT的几率大约高60%(经混杂因素调整的优势比[OR]为1.67[1.22 - 2.29])。
在接受针对性筛查的人群中,约五分之一的人患有IGT、IFG或T2DM,南亚裔人群中的患病率更高。与之前发表的研究相比,南亚人中未被检测出的T2DM患病率较低,这可能是由于该群体对自身高风险的认识有所提高。